Evidence map›Paper›PMID 35818129›Full record

ReviewThe Journal of international medical research2022

Autosomal dominant hypocalcemia with a novel

Yingying Wu, Chao Zhang, Xiaojun Huang, Li Cao, Shihua Liu, Ping Zhong

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The Journal of international medical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yingying WuDepartment of Neurology, Suzhou Hospital of Anhui Medical University, Suzhou, China.
Chao ZhangDepartment of Neurology, Suzhou Hospital of Anhui Medical University, Suzhou, China.
Xiaojun HuangDepartment of Neurology and Instituted of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Li CaoDepartment of Neurology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Shihua LiuDepartment of Neurology, Suzhou Hospital of Anhui Medical University, Suzhou, China.
Ping ZhongDepartment of Neurology, Suzhou Hospital of Anhui Medical University, Suzhou, China.ORCID https://orcid.org/0000-0002-3370-8000
Anhui Medical University · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autosomal dominant hypocalcemia type 1 (ADH1) is a rare inherited disorder characterized by hypocalcemia with low parathyroid hormone (PTH) levels and high urinary calcium. Its clinical presentation varies from mild asymptomatic to severe hypocalcemia. It is caused by gain-of-function mutations in the calcium-sensing receptor gene (

Indexed as

HypercalcemiaHypocalcemiaHypoparathyroidismCalciumHumansHypercalciuriaMutationReceptors, Calcium-SensingCalciumCASR protein, humanReceptors, Calcium-SensingAutosomal dominant hypocalcemia type 1calcificationCASRhyperphospheremiahypoparathyroidismseizure

Identifiers

PMID35818129
PMCPMC9280832
OpenAlexW4285025591

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.